Related Experiment Video
Updated: Nov 30, 2025

04:06
Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
2.8K
Changes in peripheral and central sensitization in patients undergoing occipital nerve stimulation
Theresa Wodehouse1, Anish Bahra1, Vivek Mehta1
1Barts Neuromodulation Unit & Pain and Anaesthesia Research Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
British Journal of Pain
|November 16, 2020
Summary
Occipital nerve stimulation (ONS) improved conditioned pain modulation (CPM) in migraine patients, suggesting it reduces central sensitization. This treatment normalized CPM response within two weeks, showing sustained benefits over twelve months.
Area of Science:
- Neuroscience
- Pain Management
- Neuromodulation
Background:
- Central sensitization and impaired conditioned pain modulation (CPM) are implicated in migraine progression.
- Migraine patients may experience allodynia due to heightened nociceptor sensitivity.
- Occipital nerve stimulation (ONS) targets C1-C3 nerve branches to modulate nociceptive pathways.
Purpose of the Study:
- To investigate peripheral and central sensitization in migraine patients receiving percutaneous ONS.
- To evaluate the impact of ONS on CPM and quantitative sensory testing (QST) parameters.
Main Methods:
- Observational study involving 13 migraine patients undergoing ONS.
- Quantitative sensory testing (QST) performed pre- and post-ONS at multiple time points up to 12 months.
- Utilized dual Octrode leads and a rechargeable implantable pulse generator (IPG).
Main Results:
- Pre-ONS, patients exhibited impaired CPM; this normalized within 2 weeks post-ONS and remained improved for 12 months.
- No statistically significant differences were observed in pressure pain thresholds (PPTs) between pre- and post-ONS.
- ONS demonstrated a sustained positive effect on CPM response.
Conclusions:
- This study is the first to report ONS effects on central sensitization in migraine.
- ONS consistently improved CPM response, indicating a potential reduction in central sensitization.
- The normalization of CPM suggests ONS may be a viable treatment for reducing central sensitization in migraineurs.

